Tomiko Oskotsky

ORCID: 0000-0001-7393-5120 · 13 papers in corpus
article 2026
iScience ·doi:10.1016/j.isci.2026.117153

Endometriosis has limited treatment options, prompting the search for data-driven therapeutics. We previously used a transcriptomics-based computational drug repositioning pipeline and identified several drug candidates. Fenoprofen, our top…

2026
mSystems ·doi:10.1128/msystems.01498-25

The vaginal microbiome plays a central role in reproductive health. Vaginal microbiome dysbiosis is associated with many adverse reproductive health outcomes, but most studies have focused on associations at the species level. The potential…

2026
bioRxiv : the preprint server for biology ·doi:10.64898/2026.07.17.739227

Transcriptome-based drug repurposing can accelerate therapeutic discovery, but is limited by fragmented resources, inconsistent quality control, and reliance on single perturbation databases. We developed CDRPipe (Computational Drug Repurpo…

2026
Toxics ·doi:10.3390/toxics14060494

Serum and plasma are the most widely used matrices in metabolomics and human biomonitoring studies; however, the optimal matrix for integrated non-targeted analysis (NTA) workflows combining metabolomics and exposomics has not been systemat…

preprint 2026
·doi:10.64898/2026.09.02.749016

Endometriosis is a chronic inflammatory disease associated with pelvic pain, infertility, and delayed diagnosis. Growing evidence suggests that altered DNA methylation contributes to disease development and could serve as a biomarker for di…

other 2025
bioRxiv : the preprint server for biology ·doi:10.1101/2025.05.28.656743

INTRODUCTION AND METHODS: Endometriosis has limited treatment options, prompting the search for novel therapeutics. We previously used a transcriptomics-based computational drug repositioning pipeline to analyze public bulk transcriptomic d…

other 2025
medRxiv : the preprint server for health sciences ·doi:10.1101/2025.02.13.25322244

Endometriosis is a prevalent, complex, inflammatory condition associated with a diverse range of symptoms and comorbidities. Despite its substantial burden on patients, population-level studies that explore its comorbid patterns and heterog…

preprint 2025
·doi:10.21203/rs.3.rs-7377239/v1

Abstract Although endometriosis is increasingly recognized as a risk factor for adverse pregnancy outcomes, large-scale analyses in U.S. populations remain limited. In this retrospective dual-cohort study, we analyzed over 4 million single…

article 2025
·doi:10.1016/j.fertnstert.2025.07.320
other 2024
iScience ·doi:10.1016/j.isci.2024.109388

Existing medical treatments for endometriosis-related pain are often ineffective, underscoring the need for new therapeutic strategies. In this study, we applied a computational drug repurposing pipeline to stratified and unstratified disea…

article 2023
·doi:10.1016/j.jmig.2023.08.392
review 2023
FASEB journal : official publication of the Federation of American Societies for Experimental Biology ·doi:10.1096/fj.202300907

Endometriosis is a common estrogen-dependent disorder wherein uterine lining tissue (endometrium) is found mainly in the pelvis where it causes inflammation, chronic pelvic pain, pain with intercourse and menses, and infertility. Recent evi…

preprint 2022
·doi:10.1101/2022.12.20.22283736

Abstract Endometriosis is a common, inflammatory pain disorder comprised of disease in the pelvis and abnormal uterine lining and ovarian function that affects ∼200 million women of reproductive age worldwide and up to 50% of those with pel…